Stefan James

111.9k total citations · 12 hit papers
496 papers, 26.7k citations indexed

About

Stefan James is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Stefan James has authored 496 papers receiving a total of 26.7k indexed citations (citations by other indexed papers that have themselves been cited), including 402 papers in Cardiology and Cardiovascular Medicine, 205 papers in Surgery and 76 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Stefan James's work include Acute Myocardial Infarction Research (221 papers), Antiplatelet Therapy and Cardiovascular Diseases (195 papers) and Coronary Interventions and Diagnostics (132 papers). Stefan James is often cited by papers focused on Acute Myocardial Infarction Research (221 papers), Antiplatelet Therapy and Cardiovascular Diseases (195 papers) and Coronary Interventions and Diagnostics (132 papers). Stefan James collaborates with scholars based in Sweden, United States and United Kingdom. Stefan James's co-authors include Lars Wallentin, Robert F. Storey, Philippe Gabríel Steg, Steen Husted, Richard C. Becker, Hugo A. Katus, Jay Horrow, Robert A. Harrington, Claes Held and Kenneth W. Mahaffey and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Stefan James

471 papers receiving 25.9k citations

Hit Papers

Ticagrelor versus Clopidogrel in Patients with Acute Coro... 2007 2026 2013 2019 2009 2007 2010 2017 2010 1000 2.0k 3.0k 4.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefan James Sweden 76 21.6k 11.5k 4.2k 4.1k 1.9k 496 26.7k
Gilles Montalescot France 80 23.1k 1.1× 12.3k 1.1× 3.3k 0.8× 5.8k 1.4× 2.7k 1.4× 553 28.8k
Debabrata Mukherjee United States 61 21.0k 1.0× 11.6k 1.0× 6.6k 1.6× 3.1k 0.8× 3.5k 1.9× 466 29.8k
Andrzej Budaj Poland 56 19.1k 0.9× 7.9k 0.7× 3.3k 0.8× 3.4k 0.8× 2.6k 1.4× 228 26.9k
Peter B. Berger United States 76 16.2k 0.7× 10.5k 0.9× 3.6k 0.9× 3.5k 0.9× 2.5k 1.3× 360 22.6k
A. Michael Lincoff United States 92 20.8k 1.0× 14.0k 1.2× 4.6k 1.1× 5.5k 1.4× 2.7k 1.4× 418 31.1k
Marco Valgimigli Italy 80 23.4k 1.1× 15.2k 1.3× 7.0k 1.7× 3.7k 0.9× 3.9k 2.1× 526 29.6k
Pierre Théroux Canada 74 19.0k 0.9× 10.2k 0.9× 6.4k 1.5× 3.1k 0.8× 1.2k 0.6× 273 26.4k
L. Kristin Newby United States 75 18.6k 0.9× 6.3k 0.5× 4.7k 1.1× 1.7k 0.4× 1.4k 0.8× 339 26.4k
Julinda Mehilli Germany 80 21.5k 1.0× 15.1k 1.3× 7.2k 1.7× 2.5k 0.6× 4.3k 2.3× 374 27.3k
Dean J. Kereiakes United States 86 19.8k 0.9× 19.0k 1.7× 6.6k 1.6× 2.8k 0.7× 4.8k 2.6× 502 28.4k

Countries citing papers authored by Stefan James

Since Specialization
Citations

This map shows the geographic impact of Stefan James's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan James with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan James more than expected).

Fields of papers citing papers by Stefan James

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan James. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan James. The network helps show where Stefan James may publish in the future.

Co-authorship network of co-authors of Stefan James

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan James. A scholar is included among the top collaborators of Stefan James based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan James. Stefan James is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nielsen, Susanne J., Kok Wai Giang, Henrik Bjursten, et al.. (2025). Mortality and morbidity after transcatheter aortic valve implantation compared to an age- and sex-matched control population: a population-based study from the SWEDEHEART registry. European Heart Journal - Quality of Care and Clinical Outcomes. 11(5). 614–621. 1 indexed citations
2.
Buccheri, Sergio, Stefan James, Marion Mafham, et al.. (2025). Large simple randomized controlled trials—from drugs to medical devices: lessons from recent experience. Trials. 26(1). 24–24. 1 indexed citations
3.
Rodin, Sergey, Frank A. Flachskampf, Oscar E. Simonson, et al.. (2024). Left atrial dysfunction in bicuspid aortic valve patients with severe aortic stenosis is associated with post-operative atrial fibrillation following aortic valve replacement. European Heart Journal Open. 4(2). oeae020–oeae020. 3 indexed citations
4.
Stone, Gregg W., Marco Valgimigli, David Erlinge, et al.. (2024). Bivalirudin vs Heparin Anticoagulation in STEMI. Journal of the American College of Cardiology. 84(16). 1512–1524. 6 indexed citations
5.
Koul, Sasha, Elmir Ömerovic, John Andersson, et al.. (2023). Abbreviated versus standard dual antiplatelet therapy time after PCI in high bleeding risk patients with acute coronary syndrome - a report from the SWEDEHEART registry. European Heart Journal. 44(Supplement_2). 1 indexed citations
6.
Jernberg, Tomas, Joakim Alfredsson, David Erlinge, et al.. (2023). Comparison between ticagrelor and clopidogrel in myocardial infarction patients with high bleeding risk. European Heart Journal - Cardiovascular Pharmacotherapy. 9(7). 627–635. 5 indexed citations
7.
Davidsson, Pia, Susanna Eketjäll, Niclas Eriksson, et al.. (2023). Vascular endothelial growth factor-D plasma levels and VEGFD genetic variants are independently associated with outcomes in patients with cardiovascular disease. Cardiovascular Research. 119(7). 1596–1605. 8 indexed citations
8.
Kageyama, Shigetaka, Patrick W. Serruys, Scot Garg, et al.. (2022). Geographic disparity in 10-year mortality after coronary artery revascularization in the SYNTAXES trial. International Journal of Cardiology. 368. 28–38. 3 indexed citations
9.
Rylance, Rebecca, Philippe Wagner, Elmir Ömerovic, et al.. (2021). Assessing the external validity of the VALIDATE-SWEDEHEART trial. Clinical Trials. 18(4). 427–435. 1 indexed citations
10.
Mahmoodi, Bakhtawar K., Niclas Eriksson, Gerrit J.A. Vos, et al.. (2021). Factor V Leiden Does Not Modify the Phenotype of Acute Coronary Syndrome or the Extent of Myocardial Necrosis. Journal of the American Heart Association. 10(11). e020025–e020025. 3 indexed citations
11.
Yin, Dean R.P.P. Chan Pin, et al.. (2020). Risk Assessment Using Risk Scores in Patients with Acute Coronary Syndrome. Journal of Clinical Medicine. 9(9). 3039–3039. 17 indexed citations
12.
Yin, Dean R.P.P. Chan Pin, Marco Valgimigli, Stephan Windecker, et al.. (2020). Patient-tailored antithrombotic therapy following percutaneous coronary intervention. European Heart Journal. 42(10). 1038–1046. 22 indexed citations
13.
Christersson, Christina, Stefan James, Lars Lindhagen, et al.. (2019). Comparison of warfarin versus antiplatelet therapy after surgical bioprosthetic aortic valve replacement. Heart. 106(11). 838–844. 10 indexed citations
14.
Andersen, Karl, et al.. (2017). Gender differences in coronary angiography, subsequent interventions, and outcomes among patients with acute coronary syndromes. American Heart Journal. 191. 65–74. 37 indexed citations
15.
Alexander, Karen P., Giora Weisz, Kristi Prather, et al.. (2015). Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization. Circulation. 133(1). 39–47. 37 indexed citations
16.
Åkerblom, Axel, Stefan James, H. A. Katus, et al.. (2014). Efficacy and safety of ticagrelor in patients with acute coronary syndrome and heart failure : insights from the platelet inhibition and patient outcomes (PLATO) trial. European Heart Journal. 35. 202–203. 1 indexed citations
17.
Brilakis, Emmanouil S., Claes Held, Bernhard Meier, et al.. (2013). Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: Insights from the PLATelet inhibition and patient outcomes (PLATO) trial. American Heart Journal. 166(3). 474–480. 23 indexed citations
18.
Wallentin, Lars, Stefan James, Evangelos Giannitsis, et al.. (2012). Abstract 15929: Outcomes with Ticagrelor Versus Clopidogrel in Relation to High Sensitivity Troponin-T in Non-ST-Elevation Acute Coronary Syndrome Patients Managed with Early Invasive or Non-Invasive Treatment - A Substudy from the Prospective Randomized PLATelet Inhibition and Patient Outcomes (PLATO) Trial. Circulation. 126. 3 indexed citations
19.
Angerås, Oskar, Per Albertsson, Kristjan Karason, et al.. (2012). Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish Coronary Angiography and Angioplasty Registry. European Heart Journal. 34(5). 345–353. 217 indexed citations
20.
Navarese, Eliano Pio, David Austin, Paul A. Gurbel, et al.. (2012). Drug-coated balloons in treatment of in-stent restenosis: a meta-analysis of randomised controlled trials. Clinical Research in Cardiology. 102(4). 279–287. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026